Back

NorStent - Comparison of long term effects of new generation DES vs contemporary BMS on mortality, morbidity, revascularization, and quality of life.

30 August 2016 (13:00 - 13:40)
Organised by:
Congress Presentation Part of: Meet the Trialist V - NorStent PCI: long-term outcome ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Kaare Harald Bonaa

St. Olav University Hospital, Trondheim (Norway)

Access the full session

Session thumbnail
Meet the Trialist V - NorStent

The Event

Event poster

ESC Congress 2016

30 August 2016 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Outcomes of drug eluting stents vs. drug eluting balloons. A single center experience.
27 August 2023
thumbnail
Congress Presentation
Quality of life up to one year after revascularisation with percutaneous coronary intervention in patients with previous coronary artery bypass surgery.
14 June 2024
thumbnail
Congress Presentation
Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study
1 September 2020
thumbnail
Congress Presentation
Comparison of two iterations of the zotarolimus-eluting stents: an analysis of all-comer patients from two consecutive randomised clinical trials
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources